Empower Exosomes’ Therapies

Exogems is an early-stage Swiss biotech company founded to exploit the therapeutic potential of exosomes arising from a revolutionary platform built around the only in-class medical device registered in regenerative medicine by the FDA, namely Lipogems®. 

Lipogems® is a sterile single-use medical device intended for the closed-loop processing and transferring of autologous adipose tissue in a single surgical step. Its principle is based on the Mesenchymal Stem Cells (MSC) contained in the fat that are still in their niche and are more efficient and more responsive to environmental stimuli giving very strong regenerative tissues and results upon grafting. 

Our mission is to disrupt the field of inflammation and regenerative medicine by enabling consistent production of highly efficacious exosomes by using our unique Lipogems® technology combined with proven, scalable, and cost-effective biopharmaceutical manufacturing know how. 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam tincidunt lorem enim, eget fringilla turpis congue vitae. Phasellus aliquam nisi ut lorem vestibulum eleifend. Nulla ut arcu non nisi congue venenatis vitae ut ante. Nam iaculis sem nec ultrices dapibus. Phasellus eu ultrices turpis. Vivamus non

Pr. Carlo Tremolada

Founder, Chairman

MD,  Founder of Image REGENERATIVE clinic Milano; Maxillo facial, plastic

reconstructive surgeon.

Founder of Lipogems and Lipobank

Leadership Team

Dr Carmelo Bisognano

CEO

PhD in Infectious Diseases

Serial Entrepreneur (EasyMed Technologies, Dybaw inc.)

Innovation Promoter/Board Member

Dr Pierre Rocheteau

Founder, Scientific Adv

PhD in Stem Cells

MBA from ESCP

CEO at Olgram

News



For any enquiry, please contact us

c/o Biopôle

Route de la Corniche 5

1066 Epalinges

Switzerland

 (c) January 2023